Evidence map›Paper›PMID 42220676›Full record

ArticleCureus2026

Beyond Pneumonia: Autoimmune Pulmonary Alveolar Proteinosis in a Pediatric Patient.

Jessica Satei, Tarek Husien, Ibrahim Abdulhamid

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jessica SateiPediatrics, Detroit Medical Center (DMC) Children's Hospital of Michigan, Detroit, USA.
Tarek HusienPediatrics, Detroit Medical Center (DMC) Children's Hospital of Michigan, Detroit, USA.
Ibrahim AbdulhamidPediatric Pulmonology, Central Michigan University College of Medicine, Detroit, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare pediatric lung disorder marked by the accumulation of surfactant-like material within the alveoli, impairing normal gas exchange. Among its subtypes, the autoimmune form, caused by neutralizing antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF), is particularly uncommon in children and often mimics atypical infections. We describe the case of a 12-year-old girl with progressive dyspnea, hypoxia, and declining physical performance over four months. Imaging revealed diffuse bilateral ground-glass opacities, and initial treatment for atypical pneumonia showed minimal improvement. Further workup, including bronchoalveolar lavage and lung biopsy, identified alveolar spaces filled with periodic acid-Schiff (PAS)-positive proteinaceous material. Serologic testing confirmed elevated GM-CSF autoantibodies, establishing the diagnosis of autoimmune PAP. The patient required supplemental oxygen and underwent multiple whole lung lavages (WLL), ultimately achieving significant clinical improvement and functional recovery. This case underscores the importance of considering autoimmune PAP in pediatric patients with unexplained interstitial lung disease unresponsive to conventional therapy. Early testing for GM-CSF autoantibodies and timely initiation of WLL may prevent misdiagnosis and lead to favorable outcomes.

Indexed as

abnormal stat5anti-granulocyte-macrophage colony-stimulating factor antibodiesautoimmune pulmonary alveolar proteinosis (pap)bal lavagepediatrics lung fibrosis

Identifiers

PMID42220676
PMCPMC13215785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.